Marksans Pharma’s wholly owned subsidiary – Relonchem has received marketing authorization from UKMHRA for Rasagiline Relonchem 1 mg Tablets, Olmesartan 10 mg Film-coated Tablets, Olmesartan 20 mg Film-coated Tablets and Olmesartan 40 mg Film-coated Tablets.
Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.